Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Struggling Saints face tough test against surging Rams in key NFC matchup
UK PM Starmer refuses to rule out tax hikes amid budget deficit, sparking debate within Labour party.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Struggling Saints face tough test against surging Rams in key NFC matchup
UK PM Starmer refuses to rule out tax hikes amid budget deficit, sparking debate within Labour party.